Small-cell lung cancer (SCLC) is characterized by mutation of the p53 and Rb tumor suppressors, and patients face a dismal prognosis with few treatment options. SCLC can be classified into four subtypes based on the expression of certain key genetic regulators, such as ASCL1 and NEUROD1, but how these subtypes are established despite common driver events remains to be defined. Here, Voigt, Wallenburg, and colleagues show that upregulation of the pluripotency factor SOX2 following Rb loss of function is a key determinant of SCLC phenotypic diversity. Using a conditional Sox2 knockout mouse model, the authors demonstrate that SOX2 upregulation is critical for initiation of tumors from pulmonary neuroendocrine cells. Transcriptomic analysis revealed that SOX2 regulated the expression of a broad network of stemness factors, including NEUROD1 and MYC family members. These data indicate that SOX2 may be involved in regulating SCLC tumorigenesis, as well as progression from the ASCL1 subtyp....
Skip Nav Destination
Article navigation
1 December 2021
Highlights|
December 02 2021
Selected Articles from This Issue
Online ISSN: 1557-3125
Print ISSN: 1541-7786
©2021 American Association for Cancer Research
2021
American Association for Cancer Research
Mol Cancer Res (2021) 19 (12): 1971.
Related Content
This is a related article to:
Inflammation-Induced Metastatic Colonization of the Lung Is Facilitated by Hepatocyte Growth Factor-Secreting Monocyte-Derived Macrophages
This is a related article to:
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor Chemosensitization
This is a related article to:
Sox2 Is an Oncogenic Driver of Small-Cell Lung Cancer and Promotes the Classic Neuroendocrine Subtype
This is a related article to:
DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway
- Views Icon Views
- Share Icon Share
-
Tools Icon
Tools
- Search Site
-
Article Versions Icon
Versions
- Version of Record December 2 2021
Citation
Selected Articles from This Issue. Mol Cancer Res 1 December 2021; 19 (12): 1971. https://doi.org/10.1158/1541-7786.MCR-19-12-HI
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Pay-Per-View 24-Hour Access
$50.00
227
Views
Citing articles via
Advertisement